Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_provenance.
- NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_assertion description "[Recent studies have shown that Abs that target the cell-surface enzyme CD73 (ecto-5'-nucleotidase) reduce growth of primary tumors and metastasis in syngenic mice by inhibiting the catalytic activity of CD73, and thus increasing the activity of cytotoxic T lymphocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_provenance.
- NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_assertion evidence source_evidence_literature NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_provenance.
- NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_assertion SIO_000772 24043904 NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_provenance.
- NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_assertion wasDerivedFrom befree-20150227 NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_provenance.
- NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_assertion wasGeneratedBy ECO_0000203 NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP221405.RAbBmdNgfKWNfp4K0tp1Ovu0LYqMsi1jB8OGIwDThRrE8130_provenance.